Anti-inflammatory therapy
Showing 1 - 25 of >10,000
IBD Trial in Leiden (Ferrous fumarate, MonoFer)
Recruiting
- Inflammatory Bowel Diseases
- Ferrous fumarate
- MonoFer
-
Leiden, Zuid-Holland, NetherlandsLeiden University Medical Centre
Oct 12, 2022
Pancreatitis, Chronic; Diabetes; Transplant Trial in Minneapolis (etanercept, Alpha 1-Antitrypsin)
Active, not recruiting
- Pancreatitis, Chronic; Diabetes; Transplant
- etanercept
- Alpha 1-Antitrypsin
-
Minneapolis, MinnesotaUniversity of Minnesota
Aug 12, 2022
In-stent Restenosis Trial in Beijing (Colchicine, Prednisone, Aspirin)
Not yet recruiting
- In-stent Restenosis
- Colchicine
- +4 more
-
Beijing, Beijing, ChinaFuwai Hospital
Oct 15, 2023
Molar, Third, Third Molar Surgery, Soft Tissue Swelling Trial in Lisbon (Combination of corticosteroid (methylprednisolone -
Recruiting
- Molar, Third
- +4 more
- Combination of corticosteroid (methylprednisolone - Medrol, 16mg Pfizer Laboratories) therapy and non-steroidal anti-inflammatory (Ibuprofen 600mg Mylan) therapy
- Non-steroidal anti-inflammatory therapy (Ibuprofen 600mg Mylan)
-
Lisbon, PortugalImplantology Institute
Jul 9, 2023
Acute Decompensated Heart Failure, Cytokine Storm, Inflammatory Response Trial in Jerusalem (Copaxone, guideline directed
Completed
- Acute Decompensated Heart Failure
- +3 more
- Copaxone
- guideline directed medical therapy (GDMT)
-
Jerusalem, IsraelHadassah Ein Kerem medical center-hospital ,Cardiology Departmen
Aug 15, 2023
Ureteral Stent Placement, Kidney Stone Trial in Saint Louis (Ketorolac Trometamol 30Mg/1mL Injection, Normal saline)
Recruiting
- Ureteral Stent Placement
- Kidney Stone
- Ketorolac Trometamol 30Mg/1mL Injection
- Normal saline
-
Saint Louis, MissouriWashington University
Nov 22, 2022
Hiv Trial in Nice (plasma inflammatory markers, CD4/CD8 ratio)
Not yet recruiting
- Hiv
- plasma inflammatory markers
- CD4/CD8 ratio
-
Nice, FranceCHU Nice
Jan 16, 2023
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Trial in Rozzano (Rituximab)
Active, not recruiting
- Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
-
Rozzano, Milano, ItalyIstituto Clinico Humanitas
May 17, 2023
Schizophrenia Trial in Baltimore (Anti-inflammatory Combination Therapy, Placebo)
Completed
- Schizophrenia
- Anti-inflammatory Combination Therapy
- Placebo
-
Baltimore, MarylandMaryland Psychiatric Research Center
Mar 1, 2022
Cystic Fibrosis Trial in Kansas City (Losartan)
Recruiting
- Cystic Fibrosis
-
Kansas City, KansasUniversity of Kansas Medical Center
Feb 15, 2022
Spondyloarthritis, Crohn Disease, Ulcerative Colitis Trial in Pessac (blood sample, stool samples, food questionnaire)
Completed
- Spondyloarthritis
- +2 more
- blood sample
- +4 more
-
Pessac, FranceCHU de Bordeaux - service d'Hépato-gastroentérologie
May 25, 2022
Adverse Effects in the Therapeutic Use of Analgesic, Antipyretic and Anti-Inflammatory Drug, Unspecified Trial (Cocktail
Not yet recruiting
- Adverse Effects in the Therapeutic Use of Analgesic, Antipyretic and Anti-Inflammatory Drug, Unspecified
- Cocktail injection
- (no location specified)
Nov 5, 2023
Systemic Sclerosis Trial in Ankara (Cognitive Exercise Therapy Approach (BETY))
Active, not recruiting
- Systemic Sclerosis
- Cognitive Exercise Therapy Approach (BETY)
-
Ankara, TurkeyHacettepe University
Jul 12, 2022
IBD, Crohn Disease, Colitis, Ulcerative Trial in Belgium, Netherlands, Spain (Infliximab, Adalimumab)
Recruiting
- Inflammatory Bowel Diseases
- +2 more
- Infliximab
- Adalimumab
-
Gent, Belgium
- +6 more
May 17, 2022
Treatment Resistant Depression, MDD, Analgesia Trial in Brooklyn (VTS-K)
Recruiting
- Treatment Resistant Depression
- +12 more
-
Brooklyn, New YorkMaimonides Medical Center
Dec 12, 2022
Edema, Erythema, Estrogen Receptor Negative Trial in Houston (Laboratory Biomarker Analysis, Pembrolizumab)
Active, not recruiting
- Edema
- +8 more
- Laboratory Biomarker Analysis
- Pembrolizumab
-
Houston, TexasM D Anderson Cancer Center
Jan 23, 2023
Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Breast Inflammatory Carcinoma Trial in
Active, not recruiting
- Anatomic Stage IIIB Breast Cancer AJCC v8
- +4 more
- Pembrolizumab
-
Houston, TexasM D Anderson Cancer Center
Sep 30, 2022
IBD, Crohn Disease Trial in Los Angeles (Anti-inflammatory diet, Regular diet)
Recruiting
- Inflammatory Bowel Diseases
- Crohn Disease
- Anti-inflammatory diet
- Regular diet
-
Los Angeles, CaliforniaUCLA Center for Human Nutrition, 1000 Veteran Ave.
Nov 9, 2021
Unrecognized Condition Trial in Palermo (Functional Therapy)
Completed
- Unrecognized Condition
- Functional Therapy
-
Palermo, PA, ItalyUnit of Psychiatry
Oct 27, 2021
Pericarditis Acute Trial in Petach Tikva (Dexamethasone therapy, NSAID therapy)
Recruiting
- Pericarditis Acute
- Dexamethasone therapy
- NSAID therapy
-
Petach Tikva, IsraelRabin Medical Center
Sep 30, 2021
IBD, Crohn Disease, Ulcerative Colitis Trial in Hartford, Cincinnati, Columbus (2'-Fucosyllactose, Placebo)
Recruiting
- Inflammatory Bowel Diseases
- +2 more
- 2'-Fucosyllactose
- Placebo
-
Hartford, Connecticut
- +2 more
Jan 31, 2022
Colchicine and Nonsteroidal Anti-inflammatory Drug Combination
Active, not recruiting
- Renal Impairment
- +3 more
- Colchicine and NSAID
- (no location specified)
Aug 12, 2021
Prescription-grade Crystalline Glucosamine Sulfate Therapy in
Completed
- Erosive Osteoarthritis of the Hand
- Glucosamine Sulfate
-
Siena, ItalyRheumatology Unit Azienda Ospedaliera Universitaria Senese
Feb 16, 2022
ACL Injury, Pain, Magnetic Field Exposure Trial in Bologna (I-ONE® therapy, Anti-inflammatory drug)
Recruiting
- ACL Injury
- +2 more
- I-ONE® therapy
- Anti-inflammatory drug
-
Bologna, ItalyIRCCS Istituto Ortopedico Rizzoli
Apr 4, 2022